A meta-analysis conducted in 2016 revealed a staggering 74% increase in the prevalence of PD from 1990 to 2016 [2]
Indeed, in several studies it has been proposed that GST polymorphisms may be used as biomarkers for prognosis in cancer patients 39,45
In Part 3 of the Progressive Loading series, Dr
Demand surge for GLP-1: From diabetes care to lifestyle therapeutics Indias obesity and diabetes burden is expanding rapidly, creating a sustained demand base for GLP-1 therapies
What makes it interesting is that glucagon receptor: in the Phase 3 TRIUMPH program, the top dose reached weight reductions in the region of 30 percent, territory that used to belong to surgery rather than injections
Final solution should be pale blue-green, clear to very slightly turbid